24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
24/07/2019
Port de Barcelona will have a rolling highway terminal
04/07/2019
New software to promote urban district heating and cooling networks
07/06/2019
Biodiversity in danger: Barcelona Synchrotron Park’s actions
28/05/2019
The UAB ranks first according to the CYD Foundation
23/05/2019
Alba: open day, workshop and last results
25/04/2019
The UAB Scientific and Technical Services: an opportunity for BSP’s companies